SCHEMBL2362801

SCHEMBL2362801

O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)C1CC(Cc2c(F)cc(F)cc2F)CN1C(=O)Cn1cncn1

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 0.82
CYP2C9 P11712 6/20 0.82
CYP2D6 P10635 6/20 0.82
CYP3A4 P08684 3/20 0.82
BRD4 O60885 1/20 0.36
CFTR P13569 1/20 0.35
FAAH O00519 1/20 0.34
EPHX2 P34913 1/20 0.33
PDGFRB P09619 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
OPRK1 P41145 1/20 0.33
HTR2B P41595 1/20 0.33
TMEM97 Q5BJF2 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
LHCGR P22888 1/20 0.33
CFD P00746 1/20 0.32
S1PR2 O95136 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1372288 1.00 S1PR1 (0.82) S1PR1CYP2C9CYP2D6CYP3A4BRD4
SCHEMBL2187355 0.91 S1PR1 (0.81) S1PR1CYP2C9CYP2D6CYP3A4BRD4
SCHEMBL1371513 0.91 S1PR1 (0.81) S1PR1CYP2C9CYP2D6CYP3A4BRD4
SCHEMBL2171064 0.90 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL1374743 0.90 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL1374243 0.90 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL1372649 0.88 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL1373685 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL2170080 0.88 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4CFTR
SCHEMBL12151748 0.88 S1PR1 (0.83) S1PR1CYP2C9CYP2D6CYP3A4CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed